Literature DB >> 478691

Enhancement of carcinoembryonic antigen expression by interferon.

A M Attallah, C F Needy, P D Noguchi, B L Elisberg.   

Abstract

Human interferon decreased DNA but not RNA synthesis in a human colon carcinoma cell line, WiDr; in addition, there was a two- to three-fold increase in the expression of a tumor-associated antigen, carcinoembryonic antigen. In contrast, interferon had no effect on a normal human diploid cell line, WI-38. Thus, in addition to its anti-cellular effect against tumor cells, interferon can also modulate tumor antigenicity.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 478691     DOI： 10.1002/ijc.2910240109

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


  14 in total

Review 1.  Regulation of cell growth by interferon.

Authors:  M Shearer; J Taylor-Papadimitriou
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  Influence of cytokines, monoclonal antibodies and chemotherapeutic drugs on epithelial cell adhesion molecule (EpCAM) and LewisY antigen expression.

Authors:  D Flieger; A S Hoff; T Sauerbruch; I G Schmidt-Wolf
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

3.  Biosynthetic human interferon treatment of herpetic keratitis.

Authors:  G Smolin
Journal:  Trans Am Ophthalmol Soc       Date:  1983

4.  Establishment and characterization of a carcinoembryonic antigen producing cell line derived from human pancreatic exocrine cancer.

Authors:  N Yamaguchi; G Uozumi; H Ikeuchi; H Morioka; M Machino; K Kawai
Journal:  Gastroenterol Jpn       Date:  1983-12

5.  Multiple biological activities of homogeneous human alpha interferon.

Authors:  A M Attallah; K Zoon; T Folks; J Huntington; T J Yeatman
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

6.  Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer.

Authors:  Anna F Farago; Beow Y Yeap; Marcello Stanzione; Yin P Hung; Rebecca S Heist; J Paul Marcoux; Jun Zhong; Deepa Rangachari; David A Barbie; Sarah Phat; David T Myers; Robert Morris; Marina Kem; Taronish D Dubash; Elizabeth A Kennedy; Subba R Digumarthy; Lecia V Sequist; Aaron N Hata; Shyamala Maheswaran; Daniel A Haber; Michael S Lawrence; Alice T Shaw; Mari Mino-Kenudson; Nicholas J Dyson; Benjamin J Drapkin
Journal:  Cancer Discov       Date:  2019-08-15       Impact factor: 39.397

7.  Lysis of small cell carcinoma of the lung tumor cell lines by gamma interferon-activated allogeneic peripheral blood mononuclear cells: abrogation of killing by pretreatment of tumor cells with gamma interferon.

Authors:  E D Ball; K E Nichols; O S Pettengill; G D Sorenson; M W Fanger
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

8.  Pleiotropic activities of human interferons are mediated by multiple response pathways.

Authors:  R L Forti; W M Mitchell; W C Hubbard; R J Workman; J T Forbes
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

9.  Changes in CA125 release and surface expression caused by drugs in uterine cervix adenocarcinoma cells.

Authors:  T Nakai; H Sakahara; K Endo; M Shirato; H Kobayashi; M Hosono; T Saga; M Sakamoto; J Konishi
Journal:  Ann Nucl Med       Date:  1993-08       Impact factor: 2.668

10.  Cyclic-AMP-stimulated synthesis and release of carcinoembryonic antigen by pancreatic cancer cells.

Authors:  T L Sack; J R Gum; Y S Kim
Journal:  Int J Pancreatol       Date:  1988-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.